Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunity against tetanus in childhood]

G Cilla Eguiluz1, J R Sáenz Domínguez, M Urbieta Egaña

  • 1Servicio de Microbiología, Hospital Ntra. Sra. de Aránzazu, San Sebastián.

Anales Espanoles De Pediatria
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Bartonella henselae endocarditis. Report of a case and review of the literature].

Anales de medicina interna (Madrid, Spain : 1984)·2001
Same author

[Cordylobia anthropophaga cutaneous myiasis].

Revista espanola de salud publica·2001
Same author

[Responses to triple viral and tetanus vaccination in HIV-infected children].

Anales espanoles de pediatria·1996
Same author

[Microbial resistance. What to do?].

Medicina clinica·1996
Same author

[Low risk of acquiring the hepatitis C virus for the health personnel].

Medicina clinica·1992
Same author

[Cases of tetanus in Guipuzcoa].

Anales de medicina interna (Madrid, Spain : 1984)·1992

Tetanus vaccination programs show excellent immunization coverage in children and adolescents, with high levels of protective antibodies. However, protection wanes in individuals beyond the adolescent period.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Context:

  • Evaluating the effectiveness of tetanus vaccination programs in a specific region.
  • Assessing antibody levels in pediatric and adolescent populations.

Purpose:

  • To determine the prevalence of protective tetanus antitoxin antibodies in children and adolescents.
  • To evaluate the efficacy of current tetanus immunization strategies.

Summary:

  • A study utilizing passive hemagglutination and toxin-neutralization assays found 93.2% of 591 children and adolescents had protective tetanus antitoxin antibody levels (≥0.01 IU/ml).
  • Younger children (1-5 years) exhibited higher protection rates (97.5%) compared to older adolescents (16-19 years, 79.2%).
  • Antibody titers peaked in the 6-10 year age group, aligning with booster vaccination schedules, with no significant sex-based differences in protection.

Related Experiment Videos

Impact:

  • Demonstrates high tetanus vaccine effectiveness and excellent immunization coverage in the pediatric population.
  • Highlights a decline in protection among individuals post-adolescence, suggesting potential gaps in long-term immunity.
  • Provides evidence for successful public health interventions in controlling tetanus within younger demographics.